AI-driven genomic analysis could help researchers identify existing drugs that may be repurposed for subtype-specific breast ...
SALT LAKE CITY, UTAH – Researchers at the University of Utah's Department of Psychiatry and Huntsman Mental Health Institute today published a paper introducing RiskPath, an open source software ...
Yeshwanth Macha developed explainable AI models improving insurance fraud detection accuracy, transparency, compliance and ...
Would you blindly trust AI to make important decisions with personal, financial, safety, or security ramifications? Like most people, the answer is probably no, and instead, you’d want to know how it ...
When AI falters, it’s easy to blame the model. People assume the algorithm got it wrong or that the technology can’t be trusted. But here’s what I've learned after years of building AI systems at ...
Machine learning is changing the front end of drug discovery, where researchers decide which targets to pursue and which molecules deserve costly laboratory work. Its deeper test lies further ...
Artificial intelligence (AI) continues to transform industries—from finance and healthcare to marketing and logistics. Yet one persistent challenge remains: trust. Many organizations see AI models as ...
Significant advancements in understanding the molecular and cellular mechanisms of tumor progression have been made, yet challenges remain. Traditional imaging techniques like MRI, CT, and mammography ...
NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) , a premier artificial intelligence (AI) company transforming clinical trials with advanced AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results